Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular carcinoma surveillance: An evidence-based approach
Patrick Harris, Ross M Hansen, Meagan Gray, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 13, pp. 1550-1559
Open Access | Times Cited: 198

Showing 1-25 of 198 citing articles:

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Rong Fan, George Papatheodoridis, Jian Sun, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 6, pp. 1368-1378
Open Access | Times Cited: 255
Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma
Narayanan Sadagopan, Aiwu Ruth He
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1259-1259
Open Access | Times Cited: 18
Hepatocellular carcinoma surveillance: current practice and future directions
Joseph Ahn, Yi‐Te Lee, Vatche G. Agopian, et al.
Hepatoma Research (2022)
Open Access | Times Cited: 40
LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity
Mingming Fei, Xianying Li, Shuhang Liang, et al.
Cancer Letters (2024) Vol. 584, pp. 216620-216620
Open Access | Times Cited: 9
Potential Effects of Coronaviruses on the Liver: An Update
Xinyi Wang, Jianyong Lei, Zhihui Li, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 53
AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy
Changqing Wu, Chaoliu Dai, Xinyu Li, et al.
Theranostics (2022) Vol. 12, Iss. 18, pp. 7681-7698
Open Access | Times Cited: 29
Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review
Gianvito Candita, Sara Rossi, Karolina Cwiklinska, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 625-625
Open Access | Times Cited: 22
Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma
Xinrui Shi, Xia Gao, W. Liu, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 569-590
Open Access | Times Cited: 17
Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic Opportunities
Hengdong Qu, Junli Liu, Di Zhang, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1930-1930
Open Access | Times Cited: 17
Artificial intelligence for ultrasonographic detection and diagnosis of hepatocellular carcinoma and cholangiocarcinoma
Roongruedee Chaiteerakij, Darlene Ariyaskul, Kittipat Kulkraisri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma
Chuanzong Zhao, Ben Wang, Enyu Liu, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 44
Exosomal circFBLIM1 Promotes Hepatocellular Carcinoma Progression and Glycolysis by Regulating the miR-338/LRP6 Axis
Zhiwen Lai, Tianning Wei, Qingming Li, et al.
Cancer Biotherapy and Radiopharmaceuticals (2020) Vol. 38, Iss. 10, pp. 674-683
Closed Access | Times Cited: 44
Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma
Yugang Huang, Xiuwen Chen, Li Wang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 10, pp. 2933-2951
Open Access | Times Cited: 35
Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods
Zhuolin Li, Yao Lin, Bizhen Cheng, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 33
Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Prasanna Ramachandran, Gege Xu, Hector H. Huang, et al.
Journal of Proteome Research (2022) Vol. 21, Iss. 4, pp. 1083-1094
Open Access | Times Cited: 23
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review
Mounika Kanneganti, Jorge A. Marrero, Neehar D. Parikh, et al.
Liver Transplantation (2022) Vol. 28, Iss. 12, pp. 1865-1875
Open Access | Times Cited: 23
The role of myeloid-derived suppressor cells in liver cancer
Shiyue Zhou, Zixuan Zhao, Hao Zhong, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment
Fei Feng, Yue Zhao
Medical Principles and Practice (2024) Vol. 33, Iss. 5, pp. 414-423
Open Access | Times Cited: 5
Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges
Li Shen, Antonio Saviano, Derek J. Erstad, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3817-3817
Open Access | Times Cited: 38
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective
Aisling Barry, Smith Apisarnthanarax, Grainne M. O’Kane, et al.
˜The œLancet. Gastroenterology & hepatology (2020) Vol. 5, Iss. 8, pp. 765-775
Open Access | Times Cited: 36
The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening
Raphaël Girardet, Margaux Dubois, Gibran Manasseh, et al.
European Radiology (2023) Vol. 33, Iss. 10, pp. 6929-6938
Open Access | Times Cited: 11
Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
Yuqi Feng, Letian Fang, Guangwen Cao
Hepatoma Research (2025)
Open Access
Surveillance for patients at risk of hepatocellular carcinoma: how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board?
Lorenzo Lani, Giacomo Zaccherini, Edoardo G. Giannini, et al.
Hepatoma Research (2025)
Open Access
Progress of research on glucose transporter proteins in hepatocellular carcinoma
Zheng Ruan, Yanjun Wang, Lei Shi, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 3
Closed Access
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Yoshio Sumida, Masashi Yoneda, Yuya Seko, et al.
Diagnostics (2020) Vol. 10, Iss. 8, pp. 579-579
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top